WHO’s fight against resistance to artemisinin faces uphill struggle.

Five months ago the World Health Organization (WHO) called for a voluntary ban on the distribution of the antimalarial drug artemisinin on its own as opposed to in a combination treatment. But only one-third of the 40 targeted pharmaceutical companies have agreed to comply, with others remaining silent on the issue.

Read the story here.

WHO’s fight against resistance to artemisinin faces uphill struggle.

Five months ago the World Health Organization (WHO) called for a voluntary ban on the distribution of the antimalarial drug artemisinin on its own as opposed to in a combination treatment. But only one-third of the 40 targeted pharmaceutical companies have agreed to comply, with others remaining silent on the issue.

Read the story here.